<DOC>
	<DOCNO>NCT01023724</DOCNO>
	<brief_summary>Approximately 50 patient undergoing cataract surgery randomize even allocation ( 1:1 ) two treatment group , either ketorolac 0.45 % BID bromfenac 0.09 % BID . Patients instructed begin dose study medication operative eye day surgery continue dose day 14 . KOWA flare measurement perform postoperative day one postoperative day 14 . The amount anterior chamber inflammation ( flare ) objectively measure .</brief_summary>
	<brief_title>A Comparison Post Phacoemulsification Aqueous Flare Patients Using Ketorolac 0.45 % 2 Times Daily ( BID ) Bromfenac 0.09 % 2 Times Daily ( BID )</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<mesh_term>Bromfenac</mesh_term>
	<criteria>Subjects must 18 year age old Scheduled cataract surgery phacoemulsification Subject must willing comply study requirement willing give inform consent Any subject history uveitis active iritis Subject previous intraocular surgery exception refractive surgery . within 6 month No ocular use prostaglandin within 2 week surgery Use oral , injectable topical steroid , nonsteroidal antiinflammatory drug ( NSAIDs ) immunosuppressant within 14 day prior surgery Contraindications NSAIDs Active ocular infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>